This paper summarizes the current controversies surrounding the identification and disclosure
of “incidental” or “secondary” findings from genomic sequencing and the implications for …

Despite the increased utilization of genome and exome sequencing, little is known about
the actual content and process of informed consent for sequencing. We addressed this by …

Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

Purpose: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide
variety of genomic findings will be discovered as secondary or incidental findings, and there …

Objective To assess the performance of a standardized, age-based metric for scoring clinical
actionability to evaluate conditions for inclusion in newborn screening and compare it with …

The passage of the Genetic Information Non Discrimination Act (GINA) was hailed as a
pivotal achievement that was expected to calm the fears of both patients and research …

As the use of genomic technology has expanded in research and clinical settings, issues
surrounding informed consent for genome and exome sequencing have surfaced. Despite the …

Advances in genomic sequencing technology have raised fundamental challenges to the
traditional ways genomic information is communicated. These challenges will become …

Purpose Clinical genome sequencing produces uncertain diagnostic results, raising
concerns about how to communicate the method’s inherent complexities in ways that reduce …

This study describes how parents of a child referred for genetic services searched the
Internet for information, summarizes how they interpreted and evaluated the information they …